Aerovate Therapeutics (AVTE) and Jade Biosciences announced that they have entered into a definitive merger agreement for an all-stock ...
Merger to create a company focused on advancing Jade Biosciences’ portfolio of novel therapies that aim to redefine the ...
Logos Capital, Deerfield Management, OrbiMed, and Samsara BioCapital, among other leading investment management firms. The financing includes common stock and pre-funded warrants to purchase ...
Jade Biosciences, Inc., a privately held biotechnology company dedicated to developing best-in-class therapies for patients ...
Connected operations vendor Samsara also announced a new ‘privacy mode’ for drivers in vehicles, following feedback from ...
(MENAFN- GlobeNewsWire - Nasdaq) Kalaris is a clinical-stage biopharmaceutical company founded by Samsara BioCapital and focused on development of TH103, a novel, differentiated and potentially ...
Kalaris is a clinical-stage biopharmaceutical company founded by Samsara BioCapital and focused on development of TH103, a novel, differentiated and potentially transformative therapy for patients ...